Log In
Print this Print this

Carisome Prostate cMV 1.0

  Manage Alerts
Collapse Summary General Information
Company Caris Life Sciences Inc.
DescriptionBlood-based assay using circulating microvesicle (cMV) technology
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsAid in diagnosing prostate cancer in men with elevated prostate specific antigen (PSA) levels
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today